A N Gobaud1, C A Haley2, J W Wilson3, R Bhavaraju4, A Lardizabal4, B J Seaworth5, N D Goswami6. 1. Rollins School of Public Health, Emory University, Atlanta, GA. 2. Southeastern National TB Center at University of Gainesville, Gainesville, FL. 3. Mayo Clinic Center for Tuberculosis, Rochester, MN. 4. Global TB Institute at Rutgers, The State University of New Jersey, Newark, NJ. 5. Heartland National Tuberculosis Center and University of Texas Health Science Center, Tyler, TX. 6. US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Abstract
BACKGROUND: To examine the utilization of the Tuberculosis (TB) Centers of Excellence (COE) medical consultation service and evaluate how these services were being employed for patients in relation to multidrug-resistant TB (MDR-TB). METHODS: Medical consults are documented in a secure database. The database was queried for MDR-TB consultations over the period 1 January 2013-31 December 2017. All were analyzed to assess provider type, center, setting, year of call, and type of patient (pediatric vs. adult). A subgroup was randomly selected for thematic analysis. RESULTS: The centers received 1560 MDR-TB consultation requests over this period. Providers requesting consults were primarily physicians (55%). The majority of requests were from public health departments (64%) and for adult patients (80%). Four major topic areas emerged: 1) initial management of MDR-TB, 2) MDR-TB longitudinal treatment and complications, 3) management of persons exposed to MDR-TB, and 4) MDR-TB treatment completion. CONCLUSIONS: Analysis of these consultations provides insight into the type of expert advice about MDR-TB that was provided. These findings highlight topics where increased medical training and education may help to improve MDR-TB-related practices.
BACKGROUND: To examine the utilization of the Tuberculosis (TB) Centers of Excellence (COE) medical consultation service and evaluate how these services were being employed for patients in relation to multidrug-resistant TB (MDR-TB). METHODS: Medical consults are documented in a secure database. The database was queried for MDR-TB consultations over the period 1 January 2013-31 December 2017. All were analyzed to assess provider type, center, setting, year of call, and type of patient (pediatric vs. adult). A subgroup was randomly selected for thematic analysis. RESULTS: The centers received 1560 MDR-TB consultation requests over this period. Providers requesting consults were primarily physicians (55%). The majority of requests were from public health departments (64%) and for adult patients (80%). Four major topic areas emerged: 1) initial management of MDR-TB, 2) MDR-TB longitudinal treatment and complications, 3) management of persons exposed to MDR-TB, and 4) MDR-TB treatment completion. CONCLUSIONS: Analysis of these consultations provides insight into the type of expert advice about MDR-TB that was provided. These findings highlight topics where increased medical training and education may help to improve MDR-TB-related practices.
Authors: Aitua C Salami; Gala M Barden; Diana L Castillo; Mina Hanna; Nancy J Petersen; Jessica A Davila; Aanand D Naik; Daniel A Anaya Journal: J Oncol Pract Date: 2014-12-02 Impact factor: 3.840
Authors: Neela D Goswami; Sundari Mase; David Griffith; Rajita Bhavaraju; Alfred Lardizabal; Michael Lauzardo; Lisa Chen; John Wilson; Courtney Chappelle; Connie A Haley Journal: Open Forum Infect Dis Date: 2019-04-04 Impact factor: 3.835
Authors: Suzanne M Marks; Jennifer Flood; Barbara Seaworth; Yael Hirsch-Moverman; Lori Armstrong; Sundari Mase; Katya Salcedo; Peter Oh; Edward A Graviss; Paul W Colson; Lisa Armitige; Manuel Revuelta; Kathryn Sheeran Journal: Emerg Infect Dis Date: 2014-05 Impact factor: 6.883
Authors: Ashley McDowell; Michelle Haas; Barbara Seaworth; John W Wilson; Amee Patrawalla; Connie Haley; Mike Lauzardo; Miko de Bruyn; Neela D Goswami Journal: J Clin Tuberc Other Mycobact Dis Date: 2020-11-16